Dosing antibiotics in neonates: review of the pharmacokinetic data.
Antibiotics are often used in neonates despite the absence of relevant dosing information in drug labels. For neonatal dosing, clinicians must extrapolate data from studies for adults and older children, who have strikingly different physiologies. As a result, dosing extrapolation can lead to increased toxicity or efficacy failures in neonates. Driven by these differences and recent legislation mandating the study of drugs in children and neonates, an increasing number of pharmacokinetic studies of antibiotics are being performed in neonates. These studies have led to new dosing recommendations with particular consideration for neonate body size and maturation. Herein, we highlight the available pharmacokinetic data for commonly used systemic antibiotics in neonates.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- beta-Lactams
- Thienamycins
- Piperacillin, Tazobactam Drug Combination
- Piperacillin
- Penicillanic Acid
- Microbiology
- Metronidazole
- Meropenem
- Medication Reconciliation
- Infant, Newborn
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- beta-Lactams
- Thienamycins
- Piperacillin, Tazobactam Drug Combination
- Piperacillin
- Penicillanic Acid
- Microbiology
- Metronidazole
- Meropenem
- Medication Reconciliation
- Infant, Newborn